TEMPO
Live / Applied — Third extension granted (statement of use) (as of 06 Feb 2026)
What this means for you
Not registered yet, but its 16 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97594642
- Mark type
- Stylized text
- Filed
- 16 Sept 2022
- Published for opposition
- 25 Jun 2024
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Biotechnologically-formed genes for use in the manufacture of pharmaceuticals and therapeutics
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; manufacturing services for others in the field of pharmaceuticals
- Class 042 — Scientific and technological services: Research in the field of gene editing technology; research and development in the pharmaceutical and biotechnology fields; biotechnology research; Research and development in the pharmaceutical and biotechnology fields, namely, development of gene editing platforms for manufacturing pharmaceuticals
Owner
- Tune Therapeutics, Inc., Seattle, WA, US
- Tune Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 06 Feb 2026 — SOU EXTENSION 3 GRANTED
- 05 Feb 2026 — SOU EXTENSION 3 FILED
- 05 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2025 — SOU EXTENSION 2 GRANTED
- 23 Jul 2025 — SOU EXTENSION 2 FILED
- 23 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jan 2025 — SOU EXTENSION 1 GRANTED
- 21 Jan 2025 — SOU EXTENSION 1 FILED
- 21 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION
- 05 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED